4//SEC Filing
Salzmann Peter 4
Accession 0001764013-24-000098
CIK 0001764013other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 4:15 PM ET
Size
5.8 KB
Accession
0001764013-24-000098
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Salzmann Peter
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2024-05-22$29.65/sh−16,163$479,233→ 1,036,716 total
Footnotes (2)
- [F1]On August 17, 2022, the holder was granted 451,264 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on August 19, 2022, of which 28,204 of these RSUs vested on May 17, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.31 - $30.02 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001796309
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 4:15 PM ET
- Size
- 5.8 KB